Thomas Gesibert, Virology Journal Section Editor, discusses the African green monkey as an accurate model of COVID-19 and provides new insight into several important aspects of the virus in a recently published report. In this paper, the authors tell us more in this blog post.
Featured Article: African green monkeys as an accurate model of COVID-19
New Section: Clinical Virology
We are excited to announce a new section for Virology Journal, Clinical Virology, edited by Dr. Fred Kibenge. The Clinical Virology section covers the clinical aspects of pathogenic viruses in individual hosts and populations of humans, animals, or plants. This includes the study of viral diseases, laboratory diagnosis, treatment (antiviral therapies), and control (biocontainment and vaccines) using classical, molecular, or immunological methods. Studies, including the virome, virus-host interactions, and epidemiology of viral infections, are encouraged.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Call For Papers
- Coronaviruses: emerging and re-emerging pathogens in humans and animals
- Viruses as targets and vectors
- Bacteriophage ecology and evolution
- Bacteriophage based technologies for veterinary applications
- Contribution of climate change to the spread of infectious diseases
Coronaviruses: emerging and re-emerging pathogens in humans and animals
This thematic series emphasizes advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of different emerging and re-emerging coronaviruses.
Edited by Susanna K. P. Lau and Siddharth Sridhar
Viruses as targets and vectors
The field of gene therapy for viral infections and use of viruses to deliver therapeutic sequences is now poised at an interesting phase. This series, themed on targeting viruses and use of recombinant viruses as vectors, reports on significant developments and challenges in this exciting field.
Edited by Prof Patrick Arbuthnot
Bacteriophage ecology and evolution
A series focusing on phage population and community ecology, phage-host interaction, and integrated genomics and post-genomics approaches in microbial ecology are welcome.
Edited by Hugo Oliveira and Joana Azeredo
Bacteriophage based technologies for veterinary applications
A series focusing phage therapy, antimicrobial phage enzymes, phage vaccines, phage diagnosis tools for veterinary applications are welcome.
Edited by Ana Oliveira and Joana Azeredo
Contribution of climate change to the spread of infectious diseases
This cross-journal collection brings together in one place articles outlining those diseases (and their vectors) that are likely to spread or are already spreading across borders due to the effects of climate change.
Articles
-
-
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV
-
BK polyomavirus infection promotes growth and aggressiveness in bladder cancer
-
Characterization of codon usage pattern in SARS-CoV-2
-
Identification of the largest non-essential regions of the C-terminal portion in 3A protein of foot-and-mouth disease virus for replication in cell culture
Sign up to receive article alerts
Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
SARS-CoV-2 and COVID-19
Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.
Read moreAims and scope
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
Journal Sections
Clinical Virology: Fred Kibenge, University of Prince Edward Island, Canada
Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Alan McLachlan, University of Illinois at Chicago, USA
Herpes viruses: Blossom Damania, University of North Carolina at Chapel Hill, USA
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: Bert Rima, Queen’s University Belfast, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Chikara Masuta, Hokkaido University, Japan
Positive-strand RNA viruses: Alexander A Khromykh, University of Queensland, Australia
Retroviruses: Linda Chelico, University of Saskatchewan, Canada
Veterinary DNA viruses: Klaus Osterrieder, Freie Universität Berlin, Germany
Veterinary RNA viruses: Siba Samal, University of Maryland, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal
Announcing the launch of In Review
Virology Journal, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Linfa Wang, Editor-in-Chief
Prof Wang is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, and an honorary professor at the University of Melbourne and the Chinese Academy of Sciences. He is an international leader in the field of emerging zoonotic viruses and virus-host interaction, specialising in bat-borne viruses. After completing his Bachelor's degree in 1982 at the East China Normal University, he went on to obtain his PhD at the University of California, Davis. In 1990, he joined the CSIRO, Australian Animal Health Laboratory where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus.
Prof Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences, many top scientific publications, five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Prof Wang was elected as a Fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases.
Follow
Annual Journal Metrics
-
Speed
64 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
122 days from submission to acceptance
21 days from acceptance to publication
Citation Impact
2.579 - 2-year Impact Factor
2.646 - 5-year Impact Factor
0.969 - Source Normalized Impact per Paper (SNIP)
1.045 - SCImago Journal Rank (SJR)
Usage
1,155,090 Downloads
595 Altmetric mentions
